IQVIA (IQV)
(Delayed Data from NYSE)
$231.76 USD
+0.39 (0.17%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $231.63 -0.13 (-0.06%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Revenues: Technology & Analytics Solutions
- 5,862.00
- 5,746.00
- 5,534.00
- 4,858.00
- 4,486.00
- Revenue - Line of Business (LOBR)
- Revenues: Research & Development Solution
- 8,395.00
- 7,921.00
- 7,556.00
- 5,760.00
- 5,788.00
- Revenue - Line of Business (LOBR)
- Revenues: Contract Sales & Medical Solutions
- 727.00
- 743.00
- 784.00
- 741.00
- 814.00
- Revenue - Geographic (GEOR)
- Revenues: Americas
- 7,552.00
- 7,048.00
- 6,848.00
- 5,419.00
- 5,462.00
- Revenue - Geographic (GEOR)
- Revenues: Europe and Africa
- 4,459.00
- 4,366.00
- 4,357.00
- 3,695.00
- 3,477.00
- Revenue - Geographic (GEOR)
- Revenues: Asia-Pacific
- 2,973.00
- 2,996.00
- 2,669.00
- 2,245.00
- 2,149.00
- Income - Line of Business (LOBI)
- Segment Profit: Technology & Analytics Solution
- 1,490.00
- 1,550.00
- 1,458.00
- 1,216.00
- 1,101.00
- Income - Line of Business (LOBI)
- Segment Profit: Research & Development Solutions
- 1,915.00
- 1,695.00
- 1,476.00
- 1,048.00
- 1,141.00
- Income - Line of Business (LOBI)
- Segment Profit: Contract Sales & Medical Solutions
- 49.00
- 42.00
- 75.00
- 57.00
- 52.00
- Non Financial / Operating Metric (NFM)
- Backlog
- 29.70
- 27.20
- 24.80
- 22.60
- 19.00